Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2013 Annual Meeting | BRAINS Colloquium: The BRAINS Behind Your Business

Saturday 04/26/14
01:00 PM - 04:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Colloquium
David A. Evans, MBA, DÂé¶¹´«Ã½Ó³»­
Practice Management
Participants should gain a better understanding of: how to comply with regulatory programs and incentive programs facing neurologists and how to access the financial impact of these incentives and penalties; the benefits of implementation of a successful accountable care organization; and how to implement an electronic medical record that will qualify for incentive funds.
No CME available
Other, General Neurologist, Non-neurologist
Case-based, Didactic, Interactive
Event Timeline
01:00 PM - 01:15 PM Introduction
David A. Evans, MBA, DÂé¶¹´«Ã½Ó³»­
01:15 PM - 02:00 PM Regulatory Influences on the Practice of Neurology
David A. Evans, MBA, DÂé¶¹´«Ã½Ó³»­
02:00 PM - 02:15 PM Break
02:15 PM - 03:00 PM The Evolution of an Accountable Care Organization (ACO) at an Academic Medical Center
Gregory Zalesak
03:00 PM - 03:45 PM "You Call That Attest"
Steven J. Zuckerman, MD, FÂé¶¹´«Ã½Ó³»­
03:45 PM - 04:00 PM Q & A Session
Faculty Disclosures
David A. Evans, MBA, DÂé¶¹´«Ã½Ó³»­ Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon Therapeutics/Amgen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Averitas . Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Mr. Evans has stock in NeuroNet GPO. Mr. Evans has stock in NeuroNet Pro. Mr. Evans has stock in NeuroDiscovery.AI.
Steven J. Zuckerman, MD, FÂé¶¹´«Ã½Ó³»­ No disclosure on file
Gregory Zalesak No disclosure on file